MedPath
Found 77 clinical trials|View Analysis
Sort by:

Effectiveness Of Radiofrequency Ablation And Stabilization In Metastatic Spine Lesions By PET Confirmation

Recruiting
Conditions
Bone Cancer Metastatic
Radiofrequency Ablation
Spine Metastases
Vertebral Metastasis
First Posted Date
2024-12-04
Last Posted Date
2024-12-04
Lead Sponsor
National and Kapodistrian University of Athens
Target Recruit Count
16
Registration Number
NCT06716294
Locations
🇬🇷

Attikon General University Hospital, Athens, Haidari, Greece

Branched Chained Amino Acid Supplement in Patients Undergoing Lower Limb Bone Cancer Curettage for Bone Metastasis

Not Applicable
Not yet recruiting
Conditions
Muscle Loss
Interventions
Dietary Supplement: branched chained amino acid
First Posted Date
2024-09-20
Last Posted Date
2024-09-20
Lead Sponsor
National Taiwan University Hospital
Target Recruit Count
40
Registration Number
NCT06604910

Enhanced Assistance During Radiotherapy for Unmet Essential Needs

Not Applicable
Recruiting
Conditions
Bone Cancer
Brain Cancer
Colorectal Cancer
Esophagus Cancer
Lymphoma
Salivary Gland Cancer
Head and Neck Cancer
Liver Cancer
Ovarian Cancer
Pancreatic Cancer
Interventions
Other: Standard assistance
Other: Enhanced assistance
First Posted Date
2024-09-03
Last Posted Date
2024-10-08
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
33
Registration Number
NCT06582849
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in Osteosarcoma

Phase 1
Not yet recruiting
Conditions
Osteosarcoma
Bone Cancer
Interventions
First Posted Date
2024-08-20
Last Posted Date
2024-08-22
Lead Sponsor
Shanghai 6th People's Hospital
Target Recruit Count
10
Registration Number
NCT06562673
Locations
🇨🇳

Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital,, Shanghai, China

A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases

Not yet recruiting
Conditions
Bone Metastases
Breast Cancer
Interventions
Other: Breast cancer patients with bone metastasis
Other: Breast cancer patients without bone metastasis
First Posted Date
2024-08-09
Last Posted Date
2024-08-09
Lead Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Target Recruit Count
3500
Registration Number
NCT06544668
Locations
🇨🇳

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China

Pediatric Oncological Orthopaedic Reconstruction

Active, not recruiting
Conditions
Bone Tumor
Bone Cancer
Interventions
Other: Analysis
First Posted Date
2024-07-26
Last Posted Date
2024-12-18
Lead Sponsor
Costantino Errani
Target Recruit Count
400
Registration Number
NCT06522165
Locations
🇮🇹

IRCCS Itituto Ortopedico Rizzoli, Bologna, BO, Italy

Proximal Femur Reconstruction Following Resection of Primary Bone Tumors: Analysis of the Clinical and Radiographic Results

Recruiting
Conditions
Bone Tumor
Bone Cancer
Interventions
Other: Analysis
First Posted Date
2024-07-03
Last Posted Date
2024-12-17
Lead Sponsor
Costantino Errani
Target Recruit Count
150
Registration Number
NCT06486506
Locations
🇮🇹

IRCCS Itituto Ortopedico Rizzoli, Bologna, BO, Italy

Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients

Phase 1
Completed
Conditions
Breast Cancer
Filgrastim Adverse Reaction
Interventions
First Posted Date
2024-02-20
Last Posted Date
2024-12-13
Lead Sponsor
Noha Mansour
Target Recruit Count
58
Registration Number
NCT06265077
Locations
🇪🇬

Mansoura University, Mansoura, Province, Egypt

Insights Into Participating in Studies for Bone Cancer

Not yet recruiting
Conditions
Bone Cancer
First Posted Date
2023-10-06
Last Posted Date
2023-10-06
Lead Sponsor
Power Life Sciences Inc.
Target Recruit Count
500
Registration Number
NCT06070259
Locations
🇺🇸

Power Life Sciences, San Francisco, California, United States

A Dose Finding Study to Treat Bone Tumor(s)

Phase 1
Recruiting
Conditions
Bone Cancer
Bone Tumor
Solid Tumor
Metastatic Cancer to the Bone
Metastatic Tumor to the Bone
Interventions
Drug: 153-Sm-DOTMP (Samarium-153-DOTMP)
First Posted Date
2023-08-23
Last Posted Date
2023-08-23
Lead Sponsor
QSAM Therapeutics, Inc.
Target Recruit Count
17
Registration Number
NCT06008483
Locations
🇺🇸

Clinical Trial Site, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath